Kawabata Y - Search Results

1

Development of inhalable nanocrystalline solid dispersion of tranilast for airway inflammatory diseases.

Onoue S, Aoki Y, Kawabata Y, Matsui T, Yamamoto K, Sato H, Yamauchi Y, Yamada S. Onoue S, et al. Among authors: kawabata y. J Pharm Sci. 2011 Feb;100(2):622-33. doi: 10.1002/jps.22299. J Pharm Sci. 2011. PMID: 20653048

2

In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy.

Onoue S, Sato H, Kawabata Y, Mizumoto T, Hashimoto N, Yamada S. Onoue S, et al. Among authors: kawabata y. J Control Release. 2009 Aug 19;138(1):16-23. doi: 10.1016/j.jconrel.2009.04.014. Epub 2009 Apr 17. J Control Release. 2009. PMID: 19376169

3

New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.

Onoue S, Misaka S, Kawabata Y, Yamada S. Onoue S, et al. Among authors: kawabata y. Expert Opin Drug Deliv. 2009 Aug;6(8):793-811. doi: 10.1517/17425240903089310. Expert Opin Drug Deliv. 2009. PMID: 19558334 Review.

4

Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.

Onoue S, Takahashi H, Kawabata Y, Seto Y, Hatanaka J, Timmermann B, Yamada S. Onoue S, et al. Among authors: kawabata y. J Pharm Sci. 2010 Apr;99(4):1871-81. doi: 10.1002/jps.21964. J Pharm Sci. 2010. PMID: 19827133

5

Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.

Kawabata Y, Yamamoto K, Debari K, Onoue S, Yamada S. Kawabata Y, et al. Eur J Pharm Sci. 2010 Feb 19;39(4):256-62. doi: 10.1016/j.ejps.2009.12.009. Epub 2009 Dec 28. Eur J Pharm Sci. 2010. PMID: 20038453

6

Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.

Onoue S, Sato H, Ogawa K, Kawabata Y, Mizumoto T, Yuminoki K, Hashimoto N, Yamada S. Onoue S, et al. Among authors: kawabata y. Int J Pharm. 2010 Oct 31;399(1-2):94-101. doi: 10.1016/j.ijpharm.2010.08.007. Epub 2010 Aug 10. Int J Pharm. 2010. PMID: 20705124

7

Stable dry powder inhaler formulation of tranilast attenuated antigen-evoked airway inflammation in rats.

Kawabata Y, Aoki Y, Matsui T, Yamamoto K, Sato H, Onoue S, Yamada S. Kawabata Y, et al. Eur J Pharm Biopharm. 2011 Jan;77(1):178-81. doi: 10.1016/j.ejpb.2010.11.005. Epub 2010 Nov 24. Eur J Pharm Biopharm. 2011. PMID: 21081161

8

Development of high-energy amorphous solid dispersion of nanosized nobiletin, a citrus polymethoxylated flavone, with improved oral bioavailability.

Onoue S, Uchida A, Takahashi H, Seto Y, Kawabata Y, Ogawa K, Yuminoki K, Hashimoto N, Yamada S. Onoue S, et al. Among authors: kawabata y. J Pharm Sci. 2011 Sep;100(9):3793-801. doi: 10.1002/jps.22585. Epub 2011 Apr 24. J Pharm Sci. 2011. PMID: 21520087

9

Inhalable dry-emulsion formulation of cyclosporine A with improved anti-inflammatory effects in experimental asthma/COPD-model rats.

Onoue S, Sato H, Ogawa K, Kojo Y, Aoki Y, Kawabata Y, Wada K, Mizumoto T, Yamada S. Onoue S, et al. Among authors: kawabata y. Eur J Pharm Biopharm. 2012 Jan;80(1):54-60. doi: 10.1016/j.ejpb.2011.10.003. Epub 2011 Oct 8. Eur J Pharm Biopharm. 2012. PMID: 22008148

10

Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.

Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S. Onoue S, et al. Among authors: kawabata y. Drug Metab Pharmacokinet. 2012;27(4):379-87. doi: 10.2133/dmpk.dmpk-11-rg-101. Epub 2012 Jan 13. Drug Metab Pharmacokinet. 2012. PMID: 22240843 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

919 results

Search Page

Filters